Montag & Caldwell Has Decreased Bristol (BMY) Position; Oneok (OKE) Sellers Increased By 4.85% Their Shorts

September 17, 2017 - By Migdalia James

Oneok Incorporated (NYSE:OKE) had an increase of 4.85% in short interest. OKE’s SI was 12.71M shares in September as released by FINRA. Its up 4.85% from 12.12M shares previously. With 2.64M avg volume, 5 days are for Oneok Incorporated (NYSE:OKE)’s short sellers to cover OKE’s short positions. The SI to Oneok Incorporated’s float is 6.08%. The stock decreased 1.20% or $0.68 on September 15, reaching $56.2. About 13.01M shares traded or 278.20% up from the average. ONEOK, Inc. (NYSE:OKE) has risen 23.81% since September 17, 2016 and is uptrending. It has outperformed by 7.11% the S&P500.

Montag & Caldwell Llc decreased Bristol (BMY) stake by 56.41% reported in 2016Q4 SEC filing. Montag & Caldwell Llc sold 1.39 million shares as Bristol (BMY)’s stock declined 1.04%. The Montag & Caldwell Llc holds 1.07M shares with $62.80 million value, down from 2.47 million last quarter. Bristol now has $102.46 billion valuation. The stock decreased 0.33% or $0.21 on September 15, reaching $62.48. About 10.41 million shares traded or 75.84% up from the average. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since September 17, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 53 analyst reports since July 28, 2015 according to SRatingsIntel. The stock has “Hold” rating by Jefferies on Tuesday, March 15. The firm has “Equal Weight” rating given on Tuesday, December 1 by Barclays Capital. The stock has “Buy” rating by Jefferies on Monday, July 17. The firm has “Equal-Weight” rating by Barclays Capital given on Friday, September 9. The firm has “Hold” rating by Cowen & Co given on Monday, August 14. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Buy” rating by Jefferies on Monday, December 19. As per Friday, August 19, the company rating was maintained by UBS. The rating was maintained by Credit Suisse on Monday, May 9 with “Outperform”. Jefferies maintained the shares of BMY in report on Wednesday, August 23 with “Buy” rating. The firm earned “Market Perform” rating on Monday, January 25 by BMO Capital Markets.

Montag & Caldwell Llc increased Starbucks Corp (NASDAQ:SBUX) stake by 411,834 shares to 2.46 million valued at $136.69 million in 2016Q4. It also upped Monster Beverage Corp stake by 1.73 million shares and now owns 2.57 million shares. Intercontinental Exchange Inc (NYSE:ICE) was raised too.

Investors sentiment decreased to 0.95 in Q4 2016. Its down 0.03, from 0.98 in 2016Q3. It worsened, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Wells Fargo Mn invested in 8.89 million shares. Sii Invests Inc Wi owns 30,367 shares. Ftb Advsr Inc holds 0.14% in Bristol-Myers Squibb Co (NYSE:BMY) or 20,860 shares. Riverpoint Cap Mgmt Limited Liability Company holds 0.08% or 17,047 shares in its portfolio. Fcm Invs Tx holds 610 shares or 0.02% of its portfolio. Marco Investment Management Lc holds 0.34% or 32,912 shares in its portfolio. Moreover, Gru One Trading LP has 0.13% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 223,655 shares. Moreover, Northwestern Mutual Wealth Management has 0.06% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 92,031 shares. Focused Wealth Management Incorporated owns 9,747 shares or 0.24% of their US portfolio. Hm Payson, a Maine-based fund reported 92,029 shares. Argent Capital Mngmt Ltd Limited Liability Company reported 7,958 shares stake. Oakbrook Invests Limited Liability Corp stated it has 105,104 shares or 0.4% of all its holdings. Jensen Inv Mngmt reported 0.03% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Murphy Pohlad Asset Management Limited Liability has 0.73% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 17,288 shares. Salzhauer Michael holds 0.08% or 2,786 shares.

Analysts await Bristol-Myers Squibb Co (NYSE:BMY) to report earnings on October, 26 before the open. They expect $0.75 EPS, down 2.60% or $0.02 from last year’s $0.77 per share. BMY’s profit will be $1.23B for 20.83 P/E if the $0.75 EPS becomes a reality. After $0.74 actual EPS reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts 1.35% EPS growth.

Since March 17, 2017, it had 0 buys, and 2 insider sales for $3.72 million activity. 34,000 shares were sold by ANDREOTTI LAMBERTO, worth $1.81 million. The insider Schmukler Louis S sold $282,470.

Among 16 analysts covering ONEOK (NYSE:OKE), 4 have Buy rating, 0 Sell and 12 Hold. Therefore 25% are positive. ONEOK had 51 analyst reports since August 11, 2015 according to SRatingsIntel. The stock of ONEOK, Inc. (NYSE:OKE) has “Overweight” rating given on Monday, May 9 by Barclays Capital. The company was downgraded on Friday, January 22 by Oppenheimer. As per Monday, May 15, the company rating was maintained by RBC Capital Markets. As per Tuesday, September 5, the company rating was initiated by Barclays Capital. The firm earned “Buy” rating on Tuesday, April 19 by Citigroup. As per Wednesday, June 21, the company rating was upgraded by Argus Research. The firm has “Hold” rating by Deutsche Bank given on Monday, October 10. Morgan Stanley downgraded the shares of OKE in report on Wednesday, July 5 to “Equal-Weight” rating. The rating was maintained by Citigroup on Friday, June 17 with “Buy”. Credit Suisse initiated the shares of OKE in report on Monday, September 14 with “Neutral” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :